For research use only. Not for therapeutic Use.
Glucagon Receptor Antagonist-3 (Cat No.: I002564) is a selective inhibitor targeting the glucagon receptor (GCGR), which plays a key role in glucose metabolism. By blocking GCGR signaling, it effectively reduces hepatic glucose production, offering potential therapeutic benefits for type 2 diabetes and metabolic disorders. This compound shows strong receptor affinity, favorable pharmacokinetics, and minimal off-target activity. Glucagon Receptor Antagonist-3 is valuable for studying glucagon-related pathways and developing treatments aimed at improving glycemic control and insulin sensitivity in diabetic patients.
CAS Number | 202917-17-7 |
Synonyms | 5-fluoro-2-((R)-3-((R)-1-hydroxyethyl)-2,6-diisopropyl-5-propyl-1,4-dihydropyridin-4-yl)phenol |
Molecular Formula | C22H32FNO2 |
Purity | ≥95% |
Target | GCGR |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
Reference | <p style=/line-height:25px/> </p> |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |